The Relevance of the Dopamine-D1 Receptor in the Cognitive Symptoms of Schizophrenia

被引:0
|
作者
Patricia S Goldman-Rakic
机构
[1] Section of Neurobiology,
[2] Yale University School of Medicine,undefined
来源
Neuropsychopharmacology | 1999年 / 21卷
关键词
Dopamine D; receptors; Prefrontal cortex; Memory; Cognition; Schizophrenia; Cognitive deficits; Antipsychotics;
D O I
暂无
中图分类号
学科分类号
摘要
An understanding of the role of the prefrontal cortex in normal cognitive processes has advanced our comprehension of the pathophysiology underlying the cognitive deficits in schizophrenia. Studies of single-neuron activity in monkeys during performance of delayed-response tasks have confirmed the involvement of the prefrontal cortex in working memory. The “memory fields” of prefrontal neurons are analogous to the receptive fields of visual neurons and the cellular expression of a working memory process that allows mnemonic information to guide behavior. D1-dopamine antagonists produce a dose-dependent effect (U-shaped) on the firing rate of cells with memory fields during delayed-response tasks. Disordered cognitive processes in schizophrenia can be attributed to impairment of function in the prefrontal cortex, as evidenced by hypometabolic activity in the prefrontal cortex and selective impairment in working memory tasks. Advances in our understanding of the role of D1 receptors in the cognitive deficits observed in schizophrenia should provide us with a rational basis for developing alternative antipsychotic treatments and may provide insight into the cellular basis of the disorder.
引用
收藏
页码:S170 / S180
相关论文
共 50 条
  • [31] EFFECTS OF CHRONIC DISCONTINUOUS AND CONTINUOUS TREATMENT OF RATS WITH A DOPAMINE-D1 RECEPTOR ANTAGONIST (NNC-756)
    GLENTHOJ, B
    BOLWIG, TG
    HEMMINGSEN, R
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 242 (03) : 283 - 291
  • [32] The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia
    Jentsch, JD
    Roth, RH
    NEUROPSYCHOPHARMACOLOGY, 1999, 20 (03) : 201 - 225
  • [33] The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia
    J David Jentsch
    Robert H Roth
    Neuropsychopharmacology, 1999, 20 : 201 - 225
  • [34] INVIVO ASSESSMENT OF RELEASE AND METABOLISM OF DOPAMINE IN THE VENTROLATERAL STRIATUM OF AWAKE RATS FOLLOWING ADMINISTRATION OF DOPAMINE-D1 AND DOPAMINE-D2 RECEPTOR AGONISTS AND ANTAGONISTS
    SEE, RE
    SORG, BA
    CHAPMAN, MA
    KALIVAS, PW
    NEUROPHARMACOLOGY, 1991, 30 (12A) : 1269 - 1274
  • [35] The effect of selective nigrostriatal dopamine excess on behaviors linked to the cognitive and negative symptoms of schizophrenia
    Moya, Nicolette A.
    Yun, Seongsik
    Fleps, Stefan W.
    Martin, Madison M.
    Nadel, Jacob A.
    Beutler, Lisa R.
    Zweifel, Larry S.
    Parker, Jones G.
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 (04) : 690 - 699
  • [36] Dopamine D1 receptor modulation of set shifting: the role of stress exposure
    Nikiforuk, Agnieszka
    BEHAVIOURAL PHARMACOLOGY, 2012, 23 (04): : 434 - 438
  • [37] Neurotensin NTS1-Dopamine D2 Receptor-Receptor Interactions in Putative Receptor Heteromers: Relevance for Parkinson's Disease and Schizophrenia
    Ferraro, Luca
    Beggiato, Sarah
    Borroto-Escuela, Dasiel O.
    Ravani, Laura
    O'Connor, William T.
    Tomasini, Maria C.
    Borelli, Andrea C.
    Agnati, Luigi F.
    Antonelli, Tiziana
    Tanganelli, Sergio
    Fuxe, Kjell
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2014, 15 (07) : 681 - 690
  • [38] A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia
    Girgis, Ragy R.
    Van Snellenberg, Jared X.
    Glass, Andrew
    Kegeles, Lawrence S.
    Thompson, Judy L.
    Wall, Melanie
    Cho, Raymond Y.
    Carter, Cameron S.
    Slifstein, Mark
    Abi-Dargham, Anissa
    Lieberman, Jeffrey A.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (05) : 428 - 435
  • [39] An association study between dopamine D1 receptor gene polymorphisms and the risk of schizophrenia
    Zhu, Feng
    Yan, Chun-xia
    Wang, Qian
    Zhu, Yong-sheng
    Zhao, Yan
    Huang, Jiong
    Zhang, Hong-bo
    Gao, Cheng-ge
    Li, Sheng-bin
    BRAIN RESEARCH, 2011, 1420 : 106 - 113
  • [40] ROLE OF DOPAMINE-D1 AND DOPAMINE-D2 RECEPTORS IN MEDIATING THE D-AMPHETAMINE DISCRIMINATIVE CUE
    FURMIDGE, LJ
    EXNER, M
    CLARK, D
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 202 (02) : 191 - 199